Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 3, Issue 6
June 2023
Issue Cover
All Issues
EISSN 2767-9764
Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer
Masmudur M. Rahman; Fleur van Oosterom; Junior A. Enow; Maksuda Hossain; Ami D. Gutierrez-Jensen; Mackenzie Cashen; Anne Everts; Kenneth Lowe; Jacquelyn Kilbourne; Juliane Daggett-Vondras; Timothy L. Karr; Grant McFadden
View articletitled, Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer
Supplementary data
Open the PDF for in another window
A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal Cancer
Esteban Terzo; Shruti A. Apte; Simran Padhye; Saleh Rashed; Wesley Austin; Michael Caponegro; Anupama Reddy; Shuhao Shi; Christy Wang; Roger B. Clark; David Sidransky; Vijay Modur; Vasudeo Badarinarayana
View articletitled, A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal Cancer
Supplementary data
Open the PDF for in another window
Deconstructing Olfactory Epithelium Developmental Pathways in Olfactory Neuroblastoma
John B. Finlay; Ralph Abi Hachem; David W. Jang; Nosayaba Osazuwa-Peters; Bradley J. Goldstein
View articletitled, Deconstructing Olfactory Epithelium Developmental Pathways in Olfactory Neuroblastoma
Supplementary data
Open the PDF for in another window
Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1+CD8+ T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer
Jing Wang; Xiaobo Cheng; Yanling Jin; Bili Xia; Ran Qin; Wei Zhang; Huiliang Hu; Xiaoting Mao; Liting Zhou; Jia Yan; Xiaoyan Zhang; Jianqing Xu
View articletitled, Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1<sup>+</sup>CD8<sup>+</sup> T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer
Supplementary data
Open the PDF for in another window

Advertisement

Email alerts

eTOC Alert
Close Modal
Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer
IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance
African American Prostate Cancer Displays Quantitatively Distinct Vitamin D Receptor Cistrome-transcriptome Relationships Regulated by BAZ1A
Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non–Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy
  • Online ISSN 2767-9764

AACR Journals

 

 

  • Copyright © 2022 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept